Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2019	Jun. 30, 2019
Current assets:
Cash	$ 74,627	$ 41,335
Prepaid expenses	11,834	8,005
Deposits and other receivables	1,000	1,000
Total current assets	87,461	50,340
Property and equipment, net (Note 3)	2,269	2,616
Total assets	89,730	52,956
Current liabilities:
Accounts payable and accrued expenses	790,133	715,554
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $36,500 and $36,000, respectively (Note 8)	33,900	33,400
Loans payable - affiliates (Note 4)	35,000
Deferred compensation (Note 5)	1,078,134	874,162
Loan payable and accrued interest (Note 6)	9,373,923	9,303,270
Total current liabilities	11,311,090	10,926,386
Convertible notes payable - affiliates (Note 7)	3,848,929	3,801,168
Total liabilities	15,160,019	14,727,554
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 28,417,602 and 28,068,688 shares issued, respectively; 27,713,293 and 27,364,379 shares outstanding, respectively
Additional paid-in capital	110,292,613	110,126,802
Subscription receivable - affiliates (Note 9)	(504,650)	(504,650)
Accumulated deficit	(124,907,155)	(124,346,158)
Total Bion’s stockholders’ deficit	(15,119,192)	(14,724,006)
Noncontrolling interest	48,903	49,408
Total deficit	(15,070,289)	(14,674,598)
Total liabilities and deficit	89,730	52,956
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock